
Investments
80Portfolio Exits
6Funds
4About Cambridge Innovation Capital
Cambridge Innovation Capital combines a unique relationship with the University of Cambridge with deep financial and industry links to build rapidly growing intellectual property rich companies in the Cambridge Cluster. The company is committed to support leading businesses from brilliant technologies - with the support of influential figures in the sector and a patient capital structure.

Want to inform investors similar to Cambridge Innovation Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Research containing Cambridge Innovation Capital
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Cambridge Innovation Capital in 1 CB Insights research brief, most recently on Jun 30, 2021.
Latest Cambridge Innovation Capital News
Dec 8, 2022
Innovate Cambridge gets Arm and Microsoft support to boost tech ecosystem An initiative looking to promote innovation in the Cambridge tech ecosystem has received over 100 charter signatures from the likes of Arm, Microsoft and AstraZeneca. Innovate Cambridge was launched in September by Cambridge Enterprise, Cambridge Innovation Capital and the University of Cambridge to promote the city on the global stage. It has appointed CogX co-founder and UK Government advisor Tabitha Goldstaub as executive director. Innovate Cambridge has also appointed Lord David Willetts, who served as minister for university and science and sits on the board of Cambridge-based Darktrace, as chair of its steering committee. Diarmuid O’Brien, CEO of Cambridge Enterprise and co-founder of Innovate Cambridge, told UKTN that the initiative is “trying to find a way to accelerate how quickly Cambridge could deliver impact globally” and find new opportunities to boost its tech standing. Over 100 organisations have already signed up to Innovate Cambridge’s charter, which commits members to promote the initiative, provide leadership and shape the group’s direction over the next decade. “Cambridge needs to compete with other ecosystems for talent, capital, quality of life and innovation resources and we must ensure our proposition remains both compelling and differentiated,” the charter states. In addition to Arm , Microsoft and AstraZeneca, the charter has attracted signatures from local government, two Cambridge universities, investors, infrastructure operators, accelerators and incubators. “This is a very inclusive group that brings together all of the actors needed to move the needle for the Cambridge ecosystem,” added O’Brien. Innovate Cambridge to build on tech foundations Cambridge, which has earned the nickname Silicon Fen, is home to many high-tech and life science businesses. Among them are chip designer Arm , fabless semiconductor spinout Cambridge GaN Devices and graphene startup Paragraf . “We don’t want a city or an area with those that have and those that don’t have, we want the entire Cambridge ecosystem to benefit from the impact that’s been born here,” said Michael Anstey, partner at Cambridge Innovation Capital and co-founder of Innovate Cambridge. Now the plan is for Innovate Cambridge to bring all the businesses together to “roadmap” the ambition and direction of the Cambridge area. “There’s been agreement around that it’s about impact, economic growth and improved social inclusion,” added O’Brien. Image credit: Innovate Cambridge Among the “obvious” areas that need to be addressed are attracting and keeping the necessary talent, bringing in more capital and developing opportunities in Cambridge and nearby. The charter outlines 10 areas in total that Innovate Cambridge wish to address and will be looked at in the next sixth months, with the Boston Consulting Group creating a vision for the area. Signing the initiative’s charter does not currently come with a specific set of requirements, but will signatories will consider the best intentions for the area and champion Cambridge to the government. “We’re going to get all of the key actors in a room on a regular basis over the next period to dream ambitiously for Cambridge,” said O’Brien. Once a concrete direction has been decided for Innovate Cambridge, which should be decided in the next 12 months, signatories will ramp up their own actions of support. “Whatever we do should be bulk connected to London and elevate both jurisdictions,” continued O’Brien. “But I think there’s a Cambridge story that can be told which is separate to London and needs to be framed.”
Cambridge Innovation Capital Investments
80 Investments
Cambridge Innovation Capital has made 80 investments. Their latest investment was in Seldon as part of their Series B on March 3, 2023.

Cambridge Innovation Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
3/16/2023 | Series B | Seldon | $20M | No | 7 | |
12/14/2022 | Series B | STORM Therapeutics | $30M | No | 6 | |
12/1/2022 | Series C | Carrick Therapeutics | $25M | No | 1 | |
11/15/2022 | Series B | |||||
9/12/2022 | Series A |
Date | 3/16/2023 | 12/14/2022 | 12/1/2022 | 11/15/2022 | 9/12/2022 |
---|---|---|---|---|---|
Round | Series B | Series B | Series C | Series B | Series A |
Company | Seldon | STORM Therapeutics | Carrick Therapeutics | ||
Amount | $20M | $30M | $25M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 7 | 6 | 1 |
Cambridge Innovation Capital Portfolio Exits
6 Portfolio Exits
Cambridge Innovation Capital has 6 portfolio exits. Their latest portfolio exit was Sense Biodetection on February 01, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
2/1/2023 | Acquired | 6 | |||
Date | 2/1/2023 | ||||
---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 6 |
Cambridge Innovation Capital Fund History
4 Fund Histories
Cambridge Innovation Capital has 4 funds, including Cambridge Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
4/25/2022 | Cambridge Fund II | $286.45M | 1 | ||
3/31/2019 | Cambridge Fund III | ||||
8/19/2016 | Cambridge Follow On Fund | ||||
8/12/2014 | Cambridge Cluster Fund |
Closing Date | 4/25/2022 | 3/31/2019 | 8/19/2016 | 8/12/2014 |
---|---|---|---|---|
Fund | Cambridge Fund II | Cambridge Fund III | Cambridge Follow On Fund | Cambridge Cluster Fund |
Fund Type | ||||
Status | ||||
Amount | $286.45M | |||
Sources | 1 |
Cambridge Innovation Capital Team
2 Team Members
Cambridge Innovation Capital has 2 team members, including current Managing Partner, Andrew Williamson.
Name | Work History | Title | Status |
---|---|---|---|
Andrew Williamson | True North Venture Partners, MalibuIQ, Physic Ventures, and Lawrence Livermore National Laboratory | Managing Partner | Current |
Name | Andrew Williamson | |
---|---|---|
Work History | True North Venture Partners, MalibuIQ, Physic Ventures, and Lawrence Livermore National Laboratory | |
Title | Managing Partner | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.